Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Proto LabsPRLB | Open-market sale10b5-1 plan | 09/24 | 09/25 | 5,000 sh | $95.32 | $476,604.5 | −12.5% | |
Proto LabsPRLB | Open-market sale | 06/02 | 06/04 | 2,000 sh2 trades | $77.28avg. | $154,555 | −5.8% | |
Proto LabsPRLB | Open-market sale10b5-1 plan | 05/11–05/12 | 05/13 | 23,463 sh5 trades | $69.73avg. | $1,636,187.9 | −55.7% | |
Michael R. KenisonChief Operations Officer | Proto LabsPRLB | Open-market sale10b5-1 plan | 05/07 | 05/08 | 200 sh | $70.00 | $14,000 | −0.7% |
Michael R. KenisonChief Operations Officer | Proto LabsPRLB | Open-market sale10b5-1 plan | 02/17 | 02/18 | 5,000 sh | $66.46 | $332,300 | −16.5% |
Michael R. KenisonChief Operations Officer | Proto LabsPRLB | Open-market sale10b5-1 plan | 02/06 | 02/09 | 2,500 sh | $60.00 | $150,000 | −6.8% |
Michael R. KenisonChief Operations Officer | Proto LabsPRLB | Open-market sale10b5-1 plan · Amendment | 25/11/25 | 25/12/03 | 3,048 sh | $50.17 | $152,918.16 | −9.5% |
Michael R. KenisonChief Operations Officer | Proto LabsPRLB | Open-market sale10b5-1 plan | 25/11/25 | 25/11/26 | 3,048 sh | $50.17 | $152,918.16 | −9.5% |
Rainer GawlickDirector | Proto LabsPRLB | Open-market buy | 25/08/05 | 25/08/07 | 1,715 sh | $43.79 | $75,099.85 | +4.1% |
Suresh KrishnaPresident and CEO | Proto LabsPRLB | Open-market buy | 25/08/04 | 25/08/06 | 1,725 sh | $43.51 | $75,054.75 | +10.6% |
Robert BodorPresident and CEO | Proto LabsPRLB | Open-market buy | 24/09/06 | 24/09/09 | 3,480 sh | $28.68 | $99,806.4 | +4.5% |
